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Mural nodules of ovarian mucinous borderline tumors are rare. In this study, we report a case of mural nodules of clear cell
carcinoma in an intestinal type mucinous borderline tumor of the ovary. The patient was a 54-years-old woman presented with
back and pelvic pain for 3 months. A right-sided multiloculated ovarian mass approximately 20cm was identiﬁed on the CT scan.
CA-125wasmoderatelyelevated.Sheunderwenttotalabdominalhysterectomywithbilateralsalpingo-oophorectomyandbilateral
pelvicandpara-aorticlymphadenectomy.Grossly,therightovarianmassshowedamultiloculatedcysticmasswithmucinousﬂuid.
There were papillations in the internal surface and two mural nodules were seen. Microscopic examination revealed that the cystic
mass was an intestinal type borderline mucinous tumor. The mural nodules showed a classic histology of clear cell carcinoma with
tubulocystic and papillary growth patterns. This is an extremely rare case of mural nodules of clear cell carcinoma arising in a
mucinous borderline tumor.
1.Introduction
Mucinous ovarian tumors were ﬁrst described in 1809 by
Ephraim McDowell [1]. Nowadays, mucinous ovarian
tumorsrepresentupto15%ofallovariantumors.Inthecur-
rent WHO classiﬁcations of ovarian neoplasms, mucinous
tumors are classiﬁed as surface epithelial-stromal tumors.
Primary mucinous ovarian tumors are further classiﬁed into
benign, borderline, or malignant categories depending on
their histologic features [2]. Borderline tumors account for
10% of all the mucinous tumors [3]. Mucinous borderline
tumors have been further subclassiﬁed as intestinal and
endocervical types [3]. Intestinal-type mucinous borderline
tumors tend to be more heterogeneous in composition and
may contain areas of cystadenoma and noninvasive carci-
noma [4]. Endocervical-type mucinous borderline tumors
are more closely related to borderline serous tumors [4].
On rare occasions, one or more discrete well-circumscribed
mural nodules protrude into the lumen of a cystic ovarian
epithelial neoplasm; most commonly occur in mucinous
tumors of intestinal type [4]. The nodules may be reactive
or neoplastic, and some have mixtures of both types.
Mural nodules with foci of anaplastic carcinoma, sarcoma,
sarcoma-like, and carcinosarcoma-like nodules have been
reported in the literature [5–7].
We hereby report a case of mural nodules of clear cell
carcinomainanintestinal-typeborderlinemucinousovarian
tumor. Although clear cell carcinomas have been found in
association with mucinous cystadenomas and endometriosis
in the past [8–10], to our knowledge, this is the ﬁrst report
of mural nodules of clear cell carcinoma within a mucinous
borderline tumor in the English literature.
2.CaseReport
The patient was a 54-years-old G2P2 caucasian woman
with a past medical history of hypertension, hyperlipidemia,
hernia, obesity and laparoscopic cholecystectomy. She com-
plaint of 3 months of pelvic and back pain. The pain was
described as aching, occurring on daily basis and 4/10 in
an scale of severity. She also had early satiety, occasional
nausea, and abdominal distention for the past 6 months. She
had vaginal spotting for the last 2 weeks at the moment of
presentation.2 Pathology Research International
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Figure 1: The gross appearance of one of the mural nodules.
Physical examination revealed a large pelvic-abdominal
mass, approximately 20 cm in greatest dimension. Abdomi-
nal-peilvic CT scan revealed a 20 × 10 × 7cm right
multiloculated ovarian mass. CA-125 was 43U/ml (normal
<35U/mL). The patient was scheduled for surgery. A
exploratory laparotomy was performed with frozen section
consultation. The intraoperative diagnosis was at least
borderline mucinous ovarian neoplasm. A total abdominal
hysterectomy, bilateral salpingo-oophorectomy, and bilateral
pelvic and aortic lymphadenectomy were performed. Ovar-
ian staging, including multiple biopsies and pelvic washings,
was done.
After surgery, she started 6 cycles of chemotherapy with
carboplatin/taxol.Atpresent,patientwasonhersecondcycle
without any complication related to the treatment.
3.GrossFindings
The right ovary was enlarged and completely distorted by
a mass which measured 25 × 22 × 15cm and weighted
5.2kg. The ovary had attached 7cm in length fallopian
tube which was unremarkable. The external surface of
the ovary was intact, smooth, and glistening. Upon serial
sectioning, the ovarian parenchyma was completely replaced
by a multiloculated cystic mass with mucinous ﬂuid inside
the cystic spaces. The internal surface of the cyst was mostly
smooth with areas of prominent friable papillae. Two solid
nodules, representing mural nodules, were identiﬁed and
measured 5 and 3cm in greatest dimension (Figure 1). These
mural nodules protrude into the lumen of this cystic ovarian
neoplasm and are sharply demarcated from the rest of the
lesions and showed distinctive characteristics, such as tan
discoloration,softandspongyconsistencyaswell.Focalareas
of purulent material were identiﬁed within the nodules. The
entire tumor was extensively sample in 26 blocks of paraﬃn.
4.Microscopic Findings
The ovarian tumor was composed by multiple cystic spaces
and glands with variable size and shapes; some were lined
by a single layer of intestinal-type epithelium, resembling
mucinous cystadenoma. Multiple delicate papillary infold-
ings were identiﬁed. The cells in those areas were more
crowded, stratiﬁed in two or more layers with loss of the
polarity. Occasional mitotic ﬁgures and mild to moderate
Figure 2: Intestinal mucinous borderline tumor with complex
villous architecture.
Figure 3:Thecellsoftheintestinalmuciousborderlinetumorshow
moderate cytologic atypia, inceased nuclear to cytoplasmic ratio,
and visible nucleoli. Goblet cells are present.
cellular atypia were seen (Figure 3). Severe cytological atypia
was absent. The intervening stroma was unremarkable and
areas of invasion were not seen.
The mural nodules showed abrupt transition from the
surrounding mucinous borderline tumor and microscopi-
callydisplayedatubulocystic,papillary,andfocallysolidpro-
liferation of neoplastic polyhedral cells with abundant clear
cytoplasm (Figure 4). The nuclei showed moderate to severe
cytological atypia with clumped chromatin and prominent
nucleoli (Figure 4). The stroma and papillary cores had
prominent hyalinization. Evidences of endometriosis or
endometrioid carcinoma were not seen.
The tumor was diagnosed as intestinal borderline muci-
nous tumor with mural nodules of clear cell carcinoma.
5. Discussion
Mucinous ovarian tumors are among the most diﬃcult
ovarian tumors for surgical pathologist to interprete. In the
current WHO classiﬁcation of ovarian neoplasms, mucinous
tumors are classiﬁed within the surface epithelial-stromal
tumor category [2]. Unlike the serous tumors, intestinal-
type mucinous ovarian tumors are frequently heterogeneous
in their cell type composition and degree of diﬀerentiation.
This heterogeneity causes many problems in diagnosis of
these tumors [4]. Thus, careful gross examination andPathology Research International 3
Figure 4: The mural nodule of clear cell carcinoma shows papillary
and tubulocystic patterns with prominent stromal hyalinization.
widespread sampling is important to identify the most
important component related to prognosis, such as invasive
carcinoma. In this case, we did very careful gross examina-
tion and extensive sampling with more than 20 sections per
20 cm tumor. We grossly identiﬁed two mural nodules.
Even though rare, mural nodules have been described
in benign, borderline, and malignant mucinous ovarian
tumors. The mural nodule could be benign (usually mim-
icking a malignancy) or malignant in nature [3, 4]. Bague et
al. [7] published the largest series of sarcoma-like nodules
in mucinous tumors with 10 cases. By the time of their
report, only 7 additional cases of this entity were reported.
These mural nodules tend to appear in younger patients and
they have an excellent prognosis. Several more case reports
have described mural nodules of anaplastic carcinomas,
carcinomas NOS, and sarcomas in mucinous neoplasms
[5, 6]. At least the sarcomatous nodules have been related to
older patients. The presence of a malignant mural nodule in
a mucinous tumor has serious prognostic implications for
the patient depending on the FIGO staging. It is reported
that those mural nodules composed of anaplastic carcinoma,
sarcoma, or both have a 50% mortality rate [11].
Clear cell carcinoma was ﬁrst described in 1939 by
Schiller [12]. The term of mesonephroma, a misnomer, was
introduced because it was regarded as of mesonephric rest
derivation. Scully [13] subsequently provided convincing
evidence that clear cell carcinoma is of mullerian nature
and related to endometrioid carcinoma. This tumor usually
occurs in middle-aged patients and has been associated with
endometriosis of the ovary. Stage by stage, the prognosis of
clear cell carcinoma is similar to that of patients with other
epithelial ovarian carcinomas [14].
Dutt and Berney reported for the ﬁrst time a clear cell
carcinoma arising in a mucinous cystadenoma, also with
associated endometriosis [8]. This report was controversial
and criticized by some authors as misdiagnosed areas of
mucinousmetaplasiaandnotatrulymucinouscystadenoma
[15]. Later, Uddin and Wani reported two separate cases of
clear cell carcinoma arising from a mucinous cystadenoma
[9, 10]. Our case is quite diﬀerent from the above reported
cases. First, in our case, the background is an intestinal type
mucinous borderline tumor, not benign mucinous cystade-
noma. Second, none of above reported cases described the
clear cell carcinoma as a mural nodule within the cystic
ovarian tumor, although solid areas were present in one of
the cases. Soslow mentioned in a review article that clear
cell areas are sometimes found in endocervical mucinous
borderline tumor [16]. In this case, it is intestinal type
mucinous borderline tumor and the clear cell carcinoma
is grossly and microscopically distinct from the borderline
mucinous tumor. To our knowledge, clear cell carcinoma
as a mural nodule in a borderline intestinal-type mucinous
tumor has not been previously reported in the English
literature.
In our case, the mural nodules showed characteristic
features of clear cell carcinoma with tubulocystic and
papillary architectures. The neoplastic cells had abundant
clear cytoplasm and moderate to severe atypia. The stroma
was extensively hyalinized as it is frequently described in
this entity. The intestinal type borderline mucinous tumor
areas were classical, showing cystic spaces with papillae
lined by focally stratiﬁed intestinal-type epithelium and
without evidence of stromal invasion. The overall gross
appearance and microscopic ﬁndings in both the borderline
tumor and clear cell carcinoma are classic; we feel that
immunohistochemical or special studies are not necessary
for the diagnosis.
In summary, we have reported an exceedingly rare case
of clear cell carcinoma arising in an ovarian mucinous
borderline tumor of the intestinal type. Careful gross exam-
ination and extensive sampling are crucial for the correct
diagnosis. Since malignant neoplasm within mural nodules
has a signiﬁcant impact in the prognosis of the patients,
pathologists have to be able to identify these mural nodules
accurately.
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